TrialLeukemia2017

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia.

N Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.